Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q4 2024 Earnings

30OctConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
0
0.13
0.25
0.38

Details

Expected EPS
0.0774989523
Actual EPS
0.087905954466
Surprise EPS
0.01
Surprise Percent
+13.43%

Description

Shenzhen Hepalink Pharmaceutical Group. (9989.HK) has reported earnings of 0.087905954466 per share for Q4 2024.

0 Comments

Share your thoughts